Cutting Edge: Epigenetic Regulation of Foxp3 Defines a Stable Population of CD4+ Regulatory T Cells in Tumors from Mice and Humans
Open Access
- 1 February 2015
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 194 (3) , 878-882
Abstract
CD4+ regulatory T cells (Tregs) are critical for maintaining self-tolerance and function to prevent autoimmune disease. High densities of intratumoral Tregs are generally associated with poor patient prognosis, a correlation attributed to their broad immune-suppressive features. Two major populations of Tregs have been defined, thymically derived natural Tregs (nTregs) and peripherally induced Tregs (iTregs). However, the relative contribution of nTregs versus iTregs to the intratumoral Treg compartment remains controversial. Demarcating the proportion of nTregs versus iTregs has important implications in the design of therapeutic strategies to overcome their antagonistic effects on antitumor immune responses. We used epigenetic, phenotypic, and functional parameters to evaluate the composition of nTregs versus iTregs isolated from mouse tumor models and primary human tumors. Our findings failed to find evidence for extensive intratumoral iTreg induction. Rather, we identified a population of Foxp3-stable nTregs in tumors from mice and humans.Keywords
This publication has 20 references indexed in Scilit:
- Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of MelanomaThe Journal of Immunology, 2013
- Aire-Dependent Thymic Development of Tumor-Associated Regulatory T CellsScience, 2013
- Plasticity of Foxp3+ T Cells Reflects Promiscuous Foxp3 Expression in Conventional T Cells but Not Reprogramming of Regulatory T CellsImmunity, 2012
- Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fateNature, 2010
- A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental ColitisThe Journal of Immunology, 2009
- Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas CancerJournal of Immunotherapy, 2009
- Antibody-Mediated Blockade of Integrin αvβ6 Inhibits Tumor Progression In vivo by a Transforming Growth Factor-β–Regulated MechanismCancer Research, 2008
- Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4+CD25+ regulatory T cell proliferationJournal of Experimental Medicine, 2005
- T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cellsJournal of Experimental Medicine, 2005
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 2004